Interleukin 10
|
|
This article may have too many section headers dividing up its content. Please help improve the article by merging similar sections and removing unneeded subheaders. (December 2011) |
|
|
This article may have too long an introduction for its overall length. Please help by moving some material from it into the body of the article. For more information please read the layout guide and Wikipedia's lead section guidelines. (December 2011) |
|
|
This article may be too technical for most readers to understand. Please help improve this article to make it understandable to non-experts, without removing the technical details. The talk page may contain suggestions. (December 2011) |
Interleukin-10 (IL-10 or IL10), also known as human cytokine synthesis inhibitory factor (CSIF), is an anti-inflammatory cytokine. In humans IL-10 is encoded by the IL10 gene.[1]
This cytokine is produced primarily by monocytes and to a lesser extent by lymphocytes. This cytokine has pleiotropic effects in immunoregulation and inflammation. It down-regulates the expression of Th1 cytokines, MHC class II antigens, and costimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. This cytokine can block NF-κB activity, and is involved in the regulation of the JAK-STAT signaling pathway. Knockout studies in mice suggested the function of this cytokine as an essential immunoregulator in the intestinal tract.[2] and indeed patients with Crohn's disease react favorably towards treatment with bacteria producing recombinant interleukin 10, showing the importance of interleukin 10 for counteracting excessive immunity in the human body.[3]
A study in mice has shown that interleukin-10 is also produced by mast cells, counteracting the inflammatory effect that these cells have at the site of an allergic reaction.[4]
Contents |
[edit] Function
IL-10 is capable of inhibiting synthesis of pro-inflammatory cytokines such as IFN-γ, IL-2, IL-3, TNFα and GM-CSF made by cells such as macrophages and regulatory T-cells. It also displays a potent ability to suppress the antigen-presentation capacity of antigen presenting cells. However, it is also stimulatory towards certain T cells and mast cells and stimulates B cell maturation and antibody production.
[edit] Expression
It is mainly expressed in monocytes and Type 2 T helper cells (TH2), mast cells, CD4+CD25+Foxp3+ regulatory T cells, and also in a certain subset of activated T cells and B cells. Said et al. showed that IL-10 can also be produced by monocytes upon PD-1 triggering in these cells.[5]
It is released by cytotoxic T-cells to inhibit the actions of NK cells during the immune response to viral infection.
[edit] Gene and protein structure
In humans, the IL-10 gene is located in chromosome 1 and consists of 5 exons.[1]
The IL-10 protein is a homodimer . Each subunit is 178 amino acids long.[6]
Interleukin 10 is classified as a class 2 cytokine. The Class 2 alpha-helical cytokines consist of interleukin-10 (IL-10), IL-19, IL-20, IL-22, IL-24 (Mda-7), and IL-26, interferons (IFN-alpha, -beta, -epsilon, -kappa, -omega, -delta, -tau, and -gamma) and interferon-like molecules (limitin, IL-28A, IL-28B, and IL-29) [7]
[edit] Interactions
Interleukin 10 has been shown to interact with Interleukin 10 receptor, alpha subunit.[8][9][10][11][12]
The receptor complex for interleukin-10 also requires the IL10R2 chain to initiate signaling. This ligand:receptor combination is found in birds and frogs, and likely also exists in bony fish.
[edit] References
- ^ a b Eskdale J, Kube D, Tesch H, Gallagher G (1997). "Mapping of the human IL10 gene and further characterization of the 5' flanking sequence". Immunogenetics 46 (2): 120–8. doi:10.1007/s002510050250. PMID 9162098.
- ^ "Entrez Gene: IL10 interleukin 10". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3586.
- ^ Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, van Deventer SJ, Neirynck S, Peppelenbosch MP, Steidler L (June 2006). "A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease". Clin. Gastroenterol. Hepatol. 4 (6): 754–9. doi:10.1016/j.cgh.2006.03.028. PMID 16716759.
- ^ Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ (October 2007). "Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B". Nat. Immunol. 8 (10): 1095–104. doi:10.1038/ni1503. PMID 17767162.
- ^ Elias A. Said et al. 2009, PD-1 Induced IL10 Production by Monocytes Impairs T-cell Activation in a Reversible Fashion. Nature Medicine. 2010; 452-9.
- ^ Zdanov A, Schalk-Hihi C, Gustchina A, Tsang M, Weatherbee J, Wlodawer A (June 1995). "Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma". Structure 3 (6): 591–601. doi:10.1016/S0969-2126(01)00193-9. PMID 8590020.
- ^ Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB (2004). "Interleukin-10 and related cytokines and receptors". Annu. Rev. Immunol. 22: 929–79. doi:10.1146/annurev.immunol.22.012703.104622. PMID 15032600.
- ^ Ho, A S; Liu Y, Khan T A, Hsu D H, Bazan J F, Moore K W (Dec. 1993). "A receptor for interleukin 10 is related to interferon receptors". Proc. Natl. Acad. Sci. U.S.A. (UNITED STATES) 90 (23): 11267–71. doi:10.1073/pnas.90.23.11267. ISSN 0027-8424. PMC 47963. PMID 8248239. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=47963.
- ^ Josephson, K; Logsdon N J, Walter M R (Jul. 2001). "Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site". Immunity (United States) 15 (1): 35–46. doi:10.1016/S1074-7613(01)00169-8. ISSN 1074-7613. PMID 11485736.
- ^ Tan, J C; Braun S, Rong H, DiGiacomo R, Dolphin E, Baldwin S, Narula S K, Zavodny P J, Chou C C (May. 1995). "Characterization of recombinant extracellular domain of human interleukin-10 receptor". J. Biol. Chem. (UNITED STATES) 270 (21): 12906–11. doi:10.1074/jbc.270.21.12906. ISSN 0021-9258. PMID 7759550.
- ^ Josephson, K; McPherson D T, Walter M R (Dec. 2001). "Purification, crystallization and preliminary X-ray diffraction of a complex between IL-10 and soluble IL-10R1". Acta Crystallogr. D Biol. Crystallogr. (Denmark) 57 (Pt 12): 1908–11. doi:10.1107/S0907444901016249. ISSN 0907-4449. PMID 11717514.
- ^ Hoover, D M; Schalk-Hihi C, Chou C C, Menon S, Wlodawer A, Zdanov A (May. 1999). "Purification of receptor complexes of interleukin-10 stoichiometry and the importance of deglycosylation in their crystallization". Eur. J. Biochem. (GERMANY) 262 (1): 134–41. doi:10.1046/j.1432-1327.1999.00363.x. ISSN 0014-2956. PMID 10231374.
[edit] Further reading
- Bortesi L, Rossato M, Schuster F, Raven N, Stadlmann J, Avesani L, Falorni A, Bazzoni F, Bock R, Schillberg S, Pezzotti M (2009). "Viral and murine interleukin-10 are correctly processed and retain their biological activity when produced in tobacco". BMC Biotechnol. 9: 22. doi:10.1186/1472-6750-9-22. PMC 2667500. PMID 19298643. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2667500.
- Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001). "Interleukin-10 and the interleukin-10 receptor". Annu. Rev. Immunol. 19: 683–765. doi:10.1146/annurev.immunol.19.1.683. PMID 11244051.
- Girndt M (2003). "Humoral immune responses in uremia and the role of IL-10". Blood Purif. 20 (5): 485–8. doi:10.1159/000063553. PMID 12207099.
- Beebe AM, Cua DJ, de Waal Malefyt R (2003). "The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS)". Cytokine Growth Factor Rev. 13 (4–5): 403–12. doi:10.1016/S1359-6101(02)00025-4. PMID 12220553.
- Mocellin S, Panelli MC, Wang E, et al. (2004). "The dual role of IL-10". Trends Immunol. 24 (1): 36–43. doi:10.1016/S1471-4906(02)00009-1. PMID 12495723.
- Roncarolo MG, Battaglia M, Gregori S (2004). "The role of interleukin 10 in the control of autoimmunity". J. Autoimmun. 20 (4): 269–72. doi:10.1016/S0896-8411(03)00047-7. PMID 12791310.
- Groux H, Cottrez F (2004). "The complex role of interleukin-10 in autoimmunity". J. Autoimmun. 20 (4): 281–5. doi:10.1016/S0896-8411(03)00044-1. PMID 12791313.
- Llorente L, Richaud-Patin Y (2004). "The role of interleukin-10 in systemic lupus erythematosus". J. Autoimmun. 20 (4): 287–9. doi:10.1016/S0896-8411(03)00043-X. PMID 12791314.
- Asadullah K, Sabat R, Friedrich M, et al. (2004). "Interleukin-10: an important immunoregulatory cytokine with major impact on psoriasis". Current drug targets. Inflammation and allergy 3 (2): 185–92. doi:10.2174/1568010043343886. PMID 15180472.
- Stenvinkel P, Ketteler M, Johnson RJ, et al. (2005). "IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly". Kidney Int. 67 (4): 1216–33. doi:10.1111/j.1523-1755.2005.00200.x. PMID 15780075.
- Copeland KF (2006). "Modulation of HIV-1 transcription by cytokines and chemokines". Mini reviews in medicinal chemistry 5 (12): 1093–101. doi:10.2174/138955705774933383. PMID 16375755.
[edit] External links
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||